These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27981434)

  • 41. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
    Tempelhof MW
    South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
    [No Abstract]   [Full Text] [Related]  

  • 42. Renal protection with angiotensin receptor blockers: where do we stand.
    Schmieder RE; Ruilope LM; Barnett AH
    J Nephrol; 2011; 24(5):569-80. PubMed ID: 21404225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Development trends for antihypertensive drug].
    Nishiyama A
    Nihon Rinsho; 2015 Nov; 73(11):1953-8. PubMed ID: 26619674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
    Karalliedde J; Viberti G
    J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting cytokine signaling in salt-sensitive hypertension.
    Crowley SD; Jeffs AD
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1153-F1158. PubMed ID: 27558557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory markers in essential hypertension: potential clinical implications.
    Stefanadi E; Tousoulis D; Androulakis ES; Papageorgiou N; Charakida M; Siasos G; Tsioufis C; Stefanadis C
    Curr Vasc Pharmacol; 2010 Jul; 8(4):509-16. PubMed ID: 19538178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is hypertension an immunologic disease?
    Harrison DG; Guzik TJ; Goronzy J; Weyand C
    Curr Cardiol Rep; 2008 Nov; 10(6):464-9. PubMed ID: 18950555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Research Progress of Immunity Mechanism in Hypertension].
    Liu LZ; He X; Xu M; Yu XJ; Zang WJ
    Sheng Li Ke Xue Jin Zhan; 2016 Aug; 47(4):255-9. PubMed ID: 29888895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of the Immune System in Hypertension.
    Rodriguez-Iturbe B; Pons H; Johnson RJ
    Physiol Rev; 2017 Jul; 97(3):1127-1164. PubMed ID: 28566539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammation in hypertension: current therapeutic approaches.
    Androulakis E; Tousoulis D; Papageorgiou N; Latsios G; Siasos G; Tsioufis C; Giolis A; Stefanadis C
    Curr Pharm Des; 2011 Dec; 17(37):4121-31. PubMed ID: 22204373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune Mechanisms in Hypertension.
    Harrison DG; Patrick DM
    Hypertension; 2024 Aug; 81(8):1659-1674. PubMed ID: 38881474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding sex differences in long-term blood pressure regulation: insights from experimental studies and computational modeling.
    Ahmed S; Hu R; Leete J; Layton AT
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1113-H1123. PubMed ID: 30875261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological Aspects of Hypertension.
    Carnevale D; Lembo G
    High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):91-5. PubMed ID: 27080378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Inflammatory Diseases in Hypertension.
    Bartoloni E; Alunno A; Valentini V; Luccioli F; Valentini E; La Paglia G; Bistoni O; Gerli R
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):353-361. PubMed ID: 28597352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune and inflammatory mechanisms in hypertension.
    Guzik TJ; Nosalski R; Maffia P; Drummond GR
    Nat Rev Cardiol; 2024 Jun; 21(6):396-416. PubMed ID: 38172242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications.
    Buonacera A; Stancanelli B; Malatino L
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):217-229. PubMed ID: 28405904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune mechanisms in the pathophysiology of hypertension.
    Nguyen BA; Alexander MR; Harrison DG
    Nat Rev Nephrol; 2024 Aug; 20(8):530-540. PubMed ID: 38658669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pro-inflammatory Cytokines and Resistant Hypertension: Potential for Novel Treatments?
    Pioli MR; de Faria AP
    Curr Hypertens Rep; 2019 Nov; 21(12):95. PubMed ID: 31773311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain Areas Involved in Modulating the Immune Response Participating in Hypertension and Its Target Organ Damage.
    Perrotta M; Carnevale D
    Antioxid Redox Signal; 2021 Dec; 35(18):1515-1530. PubMed ID: 34269604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.